Agency Forms Undergoing Paperwork Reduction Act Review, 39702 [E8-15630]
Download as PDF
<![CDATA[
39702
Federal Register / Vol. 73, No. 133 / Thursday, July 10, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–08–07BN]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC, or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Study to Assess Hepatitis Risk
(STAHR)—New—National Center for
AIDS Viral Hepatitis and TB Prevention,
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Hepatitis C is the most prevalent
bloodborne infection in the United
States. Approximately 3.2 million
persons are chronically infected with
hepatitis C virus (HCV).
Identifying and reaching persons at
risk for HCV infection is critical to
prevent infection. Currently the Centers
for Disease Control and Prevention
(CDC) monitor the national incidence of
acute hepatitis C through passive
surveillance of acute, symptomatic cases
of laboratory confirmed hepatitis C
cases. However, only a small group of
people with acute infection exhibit
symptoms (<25%). Passive surveillance
only captures a small fraction of acutely
infected people. Injection drug users
(IDUs) are the primary risk group for
acute hepatitis C. Thus, it is necessary
to consider strategies other than passive
surveillance for incidence monitoring.
One such strategy is to conduct serial
cross-sectional seroprevalence surveys
among populations at increased risk of
infection. Better methods of
identification of persons at risk will
enhance current surveillance efforts.
The purpose of the proposed study is
to develop and test different methods to
recruit a sample of young IDUs at risk
for HCV infection. These recruitment
methods will be compared and
contrasted to identify a methodology to
be used in ongoing serial cross-sectional
seroprevalence surveys. CDC is
requesting approval for two years.
Working with the University of
California, San Diego (UCSD), the
project will recruit a total of 1000 young
IDUs during the 2 years using several
methods. These methods are street
outreach, respondent driven sampling
and venue based. They are to be
conducted in a sexually transmitted
disease clinic and syringe exchange
program. Young IDUs who consent to
participate will be administered an
eligibility interview questionnaire by a
trained field staff member. If found
eligible, the participant will take an
audio-computer assisted self interview
that includes questions on drug use and
sexual behavior, HCV and Human
Immunodeficiency Virus (HIV) status,
knowledge of HCV, and missed
opportunities for hepatitis prevention.
The project will also collect blood
samples from each consenting
participant to test for HCV infection and
hepatitis A and B vaccination without
cost. Participants needing medical and/
or drug treatment services will be
referred to the appropriate services.
Participation in the data collection is
voluntary and there is no cost to
respondents other than their time. The
total estimated annual burden hours are
816.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Form
Young IDUs .....................................................
Eligible young IDUs ........................................
Screener .........................................................
Survey ............................................................
Dated: July 1, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–15630 Filed 7–9–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Proposed Project
jlentini on PROD1PC65 with NOTICES
[30Day–08–0576]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
VerDate Aug<31>2005
16:58 Jul 09, 2008
Jkt 214001
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Possession, Use, and Transfer of
Select Agents and Toxins (OMB Control
No. 0920–0576)—Revision—Division of
Select Agents and Toxins (DSAT),
Coordinating Office for Terrorism
Preparedness and Emergency Response
(COTPER), Centers for Disease Control
and Prevention (CDC). The revisions to
the data collection are primarily
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
1000
800
Number of
responses per
respondent
Average
burden
per response
(in hours)
1
1
5/60
55/60
changes to the guidance documents and
forms to clarify instructions, correct
editorial errors from previous
submission, and reformat the structure
of the forms based on the day-to-day
processing of these forms. This request
is for approval for three years.
Background and Brief Description
The Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002, Subtitle A of
Public Law 107–188 (42 U.S.C. 262a),
requires the United States Department
of Health and Human Services (HHS) to
regulate the possession, use, and
transfer of biological agents or toxins
(i.e., select agents and toxins) that could
pose a severe threat to public health and
safety. The Agricultural Bioterrorism
Protection Act of 2002, Subtitle B of
Public Law 107–188 (7 U.S.C. 8401),
E:\FR\FM\10JYN1.SGM
10JYN1
]]>Agencies
[Federal Register Volume 73, Number 133 (Thursday, July 10, 2008)]
[Notices]
[Page 39702]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-15630]
[[Page 39702]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-08-07BN]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC, or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
Study to Assess Hepatitis Risk (STAHR)--New--National Center for
AIDS Viral Hepatitis and TB Prevention, (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Hepatitis C is the most prevalent bloodborne infection in the
United States. Approximately 3.2 million persons are chronically
infected with hepatitis C virus (HCV).
Identifying and reaching persons at risk for HCV infection is
critical to prevent infection. Currently the Centers for Disease
Control and Prevention (CDC) monitor the national incidence of acute
hepatitis C through passive surveillance of acute, symptomatic cases of
laboratory confirmed hepatitis C cases. However, only a small group of
people with acute infection exhibit symptoms (<25%). Passive
surveillance only captures a small fraction of acutely infected people.
Injection drug users (IDUs) are the primary risk group for acute
hepatitis C. Thus, it is necessary to consider strategies other than
passive surveillance for incidence monitoring. One such strategy is to
conduct serial cross-sectional seroprevalence surveys among populations
at increased risk of infection. Better methods of identification of
persons at risk will enhance current surveillance efforts.
The purpose of the proposed study is to develop and test different
methods to recruit a sample of young IDUs at risk for HCV infection.
These recruitment methods will be compared and contrasted to identify a
methodology to be used in ongoing serial cross-sectional seroprevalence
surveys. CDC is requesting approval for two years.
Working with the University of California, San Diego (UCSD), the
project will recruit a total of 1000 young IDUs during the 2 years
using several methods. These methods are street outreach, respondent
driven sampling and venue based. They are to be conducted in a sexually
transmitted disease clinic and syringe exchange program. Young IDUs who
consent to participate will be administered an eligibility interview
questionnaire by a trained field staff member. If found eligible, the
participant will take an audio-computer assisted self interview that
includes questions on drug use and sexual behavior, HCV and Human
Immunodeficiency Virus (HIV) status, knowledge of HCV, and missed
opportunities for hepatitis prevention. The project will also collect
blood samples from each consenting participant to test for HCV
infection and hepatitis A and B vaccination without cost. Participants
needing medical and/or drug treatment services will be referred to the
appropriate services.
Participation in the data collection is voluntary and there is no
cost to respondents other than their time. The total estimated annual
burden hours are 816.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Form Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Young IDUs............................ Screener................ 1000 1 5/60
Eligible young IDUs................... Survey.................. 800 1 55/60
----------------------------------------------------------------------------------------------------------------
Dated: July 1, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E8-15630 Filed 7-9-08; 8:45 am]
BILLING CODE 4163-18-P
